Shareholder Alert: The Ademi Firm investigates whether ProAssurance Corporation is obtaining a Fair Price for its Public Shareholders

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating ProAssurance (NYSE: PRA) for possible breaches of fiduciary duty and other violations of law in its transaction with The Doctors Company.

Click here to learn how to join our investigation and obtain additional information or contact us at [e-mail] or toll-free: 866-264-3995. There is no cost or obligation to you.

In the transaction, ProAssurance shareholders will receive only $25.00 in cash per share of ProAssurance common stock, with a transaction value of approximately $1.3 billion. ProAssurance insiders will receive substantial benefits as part of change of control arrangements.

The transaction agreement unreasonably limits competing transactions for ProAssurance by imposing a significant penalty if ProAssurance accepts a competing bid. We are investigating the conduct of the ProAssurance board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.